Acurx Pharmaceuticals, Inc. (ACXP)
↓ Download CSVKey ratios (FY2025)
-151.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$8.09M | -$14.12M | — | — | — | — |
| Net Income | -$7.97M | -$14.10M | -$14.58M | -$12.09M | -$12.75M | -$4.60M |
| EPS (Diluted) | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 | $-0.74 |
| Total Assets | $7.69M | $3.86M | $7.71M | $9.38M | $13.25M | $3.22M |
| Total Liabilities | $2.42M | $3.24M | $3.04M | $2.06M | $843.9K | $522.4K |
| Shareholders' Equity | $5.27M | $615.1K | $4.67M | $7.32M | $12.41M | $2.70M |
| Operating Cash Flow | -$6.79M | -$10.38M | -$9.80M | -$7.54M | -$5.01M | -$3.35M |
| Shares Outstanding | 1.50M | 808.2K | 12.67M | 10.82M | 8.54M | 6.19M |